OraSure's diagnostic portfolio focuses primarily on detecting infectious diseases and critical medical conditions, most notably including antibodies for HIV-1 and HIV-2 (via products like the OraQuick rapid self-test), hepatitis C, and various respiratory pathogens. Additionally, through its specialized subsidiaries like DNA Genotek, the company provides advanced sample collection kits used to detect and analyze genetic material for molecular research and diagnostic applications.